Kolhe Lab

Leading the Future of Molecular Diagnostics

The Kolhe Lab is recognized for its expertise in validating emerging technologies for clinical implementation, ensuring their translation into precision oncology practice. Under the leadership of Dr. Kolhe, the lab contributes significantly to the advancement of the field through service in influential consortiums and the publication of high-impact, peer-reviewed research. The lab serves as an NCI-designated site for comprehensive genomic testing in oncology (MATCH), supporting national efforts to expand access to state-of-the-art molecular diagnostics.

Dr. Ravindra Kolhe, MD, PhD, FCAP, has co-founded the Sequencing and Oncological Informatics Academic Team (SEQUOIA), an international consortium of clinical professionals employing TSO 500. He is also a co-founder of the International Consortium for Optical Genome Mapping (ICOGM) centered on engaging the cytogenomics community in the advancement of OGM. He currently serves as the Chair of the Department of Pathology, Edgar R. Pund Distinguished Chair in Pathology, Director of the Georgia Esoteric and Molecular Laboratory, Associate Dean for Translational Research at the Medical College of Georgia, and Associate Director for Genomics at the Georgia Cancer Center.

RESEARCH NEWS

January, 2026: Kolhe Lab medical student researcher, Denton Lord, presents his poster titled "The Integration of Pathology and Clinical Informatics: Building Pathology-Driven Data Extraction Protocols in Precision Oncology Research" at the Georgia Association of Pathologists (GAP) 2026 Annual Meeting in Atlanta. Navya Katragadda and Labdhi Mehta were selected for an oral presentation on "A Multi-State Clinical and Genomic Framework to Characterize Overian Cancer Disparaities in Georgia."

November, 2025: Kolhe Lab manager Ashis Mondal and postdoctoral fellows, Ashutosh and Vishakha Vashisht, presented three posters at the Association for Molecular Pathology (AMP) Annual Meeting and Exposition. The posters were titled "Clinical Evaluation and Validation of DNBSEQ Sequencing Using a Comprehensive Genomic Panel in Solid Tumors," "Cross-Platform Evaluation of HRD Scoring: Variability, Interpretation, and Clinical Implications of Interactive vs Automated Systems," and "Cost-Effective and Rapid Mutation Profiling in Color Cancer: A Comparative Validation of the iPLEX® HS Colon MALDI-TOF Panel."